Provided by Tiger Trade Technology Pte. Ltd.

Ligand Pharmaceuticals

280.18
-6.1100-2.13%
Post-market: 280.180.00000.00%19:30 EDT
Volume:158.24K
Turnover:44.66M
Market Cap:5.59B
PE:28.85
High:286.27
Open:286.27
Low:279.87
Close:286.29
52wk High:326.63
52wk Low:157.52
Shares:19.94M
Float Shares:19.35M
Volume Ratio:0.86
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):9.71
EPS(LYR):6.13
ROE:21.96%
ROA:3.99%
PB:5.77
PE(LYR):45.71

Loading ...

Ligand price target raised to $388 from $266 at BofA

TIPRANKS
·
Jul 09

Ligand Pharmaceuticals Inc : Stifel Raises Target Price to $332 from $255

THOMSON REUTERS
·
Jul 08

Ligand CLO, Secretary Andrew Reardon Disposes of Common Shares Worth $1.53 Million

Reuters
·
Jul 07

Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), Mesoblast Limited (OtherMEOBF) and Cogstate Ltd (OtherCOGZF)

TIPRANKS
·
Jul 02

Is Ligand (LGND) Using Zero-Coupon Converts to Quietly Redefine Its Capital Allocation Playbook?

Simply Wall St.
·
Jun 29

Ligand Closes USD 700 Million 0% Convertible Senior Notes Offering Due 2031

Reuters
·
Jun 26

Press Release: Ligand Announces Closing of Convertible Senior Notes Offering

Dow Jones
·
Jun 26

BUZZ-Ligand Pharma slips after upsized $625 mln convertible debt offering

Reuters
·
Jun 23

Ligand prices upsized $625M convertible senior note offering

TIPRANKS
·
Jun 23

Ligand Pharmaceuticals Prices Upsized $625 Million Convertible Notes Offering

MT Newswires Live
·
Jun 23

Ligand Pharmaceuticals Shares Drop After Plans to Offer $550M in Notes

Dow Jones
·
Jun 22

BUZZ-Ligand Pharma eases from record on $550 mln convertible debt deal

Reuters
·
Jun 22

BRIEF-Ligand Announces Proposed Offering Of $550 Million Of Convertible Senior Notes Due 2031

Reuters
·
Jun 22

Ligand proposes offering USD 550 million of convertible senior notes due 2031

Reuters
·
Jun 22

Ligand Pharmaceuticals - Initial Purchasers Granted 13-Day Option to Buy up to $82.5 Mln Additional Notes

THOMSON REUTERS
·
Jun 22

Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031

THOMSON REUTERS
·
Jun 22

Ligand Pharmaceuticals - to Use up to $75 Mln of Proceeds for Common Stock Repurchase

THOMSON REUTERS
·
Jun 22

Ligand Pharmaceuticals - to Use Part of Proceeds for Convertible Note Hedge Transactions

THOMSON REUTERS
·
Jun 22

Ligand Pharmaceuticals (LGND) Is Up 7.6% After Institutions Snap Up the Float and Earnings Jump – Has The Bull Case Changed?

Simply Wall St.
·
Jun 20

Ligand Pharma director Stephen L. Sabba disposes of common shares worth $544,830

Reuters
·
Jun 18